Intestinal hormones, such as GLP-1, GIP, and cholecystokinin (CCK), have been demonstrated to influence the progression of T2DM by modulating glycolipid metabolism [148,149,150,151,152,153]. Here, GIP is linked to type 2 diabetes mellitus.